Global Dyslexia Treatment Market to Reach US$9.5 Billion by 2030
The global market for Dyslexia Treatment estimated at US$7.4 Billion in the year 2024, is expected to reach US$9.5 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Phonological Dyslexia Treatment, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$4.7 Billion by the end of the analysis period. Growth in the Surface Dyslexia Treatment segment is estimated at 3.7% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 6.8% CAGR
The Dyslexia Treatment market in the U.S. is estimated at US$2.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.
Global Dyslexia Treatment Market - Key Trends & Drivers Summarized
What Is Driving the Global Focus on Dyslexia Diagnosis and Management?
Dyslexia, a neurological learning disorder characterized by difficulties in reading, spelling, and language processing, affects approximately 5-15% of the global population. Growing awareness of neurodevelopmental disorders and their long-term academic and social impact has led to earlier diagnosis and increased investment in effective intervention strategies. Educational systems in North America, Europe, and Asia-Pacific are integrating dyslexia screening at primary school levels, facilitating timely treatment and accommodation plans.
The psychological burden of dyslexia-including anxiety, low self-esteem, and dropout risk-is prompting healthcare systems to integrate educational and psychological support frameworks. Early intervention has been shown to significantly improve literacy and social outcomes, fueling demand for evidence-based therapies and assistive technologies.
What Innovations Are Reshaping Dyslexia Treatment Modalities?
Technological advancements are transforming how dyslexia is treated and managed. Digital learning platforms, AI-powered phonics apps, and gamified literacy tools are enabling personalized therapy that adapts to a child’s learning pace. Wearable neurofeedback devices and speech therapy integrations are also helping improve cognitive engagement during reading exercises.
In parallel, multidisciplinary approaches involving neurologists, educators, and psychologists are becoming the norm. Tools like fMRI and EEG are being used to study the neurological basis of dyslexia, guiding the development of brain-based interventions. Pharmaceutical research is exploring the potential of nootropics and neurostimulants, though drug-based treatment remains in experimental stages.
Where Is Treatment Access Expanding and Evolving?
Global education reforms, particularly in high-income nations, are increasingly including dyslexia-friendly curricula, teacher training, and legal mandates for learning accommodations. Developing regions are beginning to follow suit through NGO-driven literacy campaigns and mobile education platforms targeting underserved communities.
Therapy providers are offering hybrid models, combining in-person sessions with teletherapy to reach children in remote areas. The private sector is investing in specialized learning centers and edtech solutions, while insurance providers in select regions are starting to reimburse psychological assessments and therapy sessions for learning disabilities.
What Is Driving Market Growth and Therapeutic Innovation?
The growth in the dyslexia treatment market is driven by several factors including expanding diagnostic infrastructure, rising demand for inclusive education, and the proliferation of digital therapeutic tools. Government mandates for early intervention, especially in Europe and North America, are creating robust demand for assessment and support services.
Technology providers are investing in AI-driven tutoring and brain-training apps that are scalable and evidence-backed. Meanwhile, growing parental awareness and advocacy movements are pressuring school systems to adopt universal screening and accommodation standards. These forces are jointly shaping a dynamic market that is expected to see continued expansion in both educational and clinical domains.
SCOPE OF STUDY:
The report analyzes the Dyslexia Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Type (Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia, Other Types); Drug Class (Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors, Other Drug Classes); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 42 Featured) -
Alkem Laboratories Ltd.
Amneal Pharmaceuticals LLC
ANI Pharmaceuticals Inc.
AstraZeneca PLC
Bionpharma Inc.
Breckenridge Pharmaceutical Inc.
DK Pharmachem Pvt Ltd.
Eli Lilly and Company
Endo Pharmaceuticals Inc.
GSK plc
Ironshore Pharmaceuticals Inc.
Jubilant Pharma Limited
Lupin Limited
Mallinckrodt Pharmaceuticals
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Ltd.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.
We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.
As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.
To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!
APRIL 2025: NEGOTIATION PHASE
Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.
JULY 2025 FINAL TARIFF RESET
Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.
Reciprocal and Bilateral Trade & Tariff Impact Analyses:
USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.
Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.
COMPLIMENTARY PREVIEW
Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Dyslexia Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Early Diagnosis Rates Drive Demand for Evidence-Based Interventions in Dyslexia Treatment
Advances in Neuroscience Propel Development of Targeted Cognitive and Language Processing Therapies
Integration of Gamified Learning Platforms Enhances Engagement in Dyslexia Education Programs
Use of AI and Machine Learning Algorithms Improves Personalization of Reading Intervention Tools
Public Policy Reforms in Education Support Increased Access to Dyslexia Screening and Treatment
Adoption of Multisensory Teaching Approaches Gains Traction Across School Systems Globally
Growth in Online Learning Platforms Creates Opportunities for Digital Dyslexia Therapy Solutions
Rising Parental Awareness and Advocacy Spurs Demand for Early Intervention Programs
Neuroplasticity Research Enhances Scientific Understanding of Dyslexia Remediation Pathways
Voice and Speech Recognition Technologies Improve Accessibility in Digital Reading Aids
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Dyslexia Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Dyslexia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Dyslexia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Dyslexia Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Phonological Dyslexia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Phonological Dyslexia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Phonological Dyslexia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Surface Dyslexia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Surface Dyslexia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Surface Dyslexia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Double Deficit Dyslexia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Double Deficit Dyslexia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Double Deficit Dyslexia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Antihistamines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Antihistamines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Antihistamines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Central Nervous Stimulant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Central Nervous Stimulant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: World 15-Year Perspective for Central Nervous Stimulant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Selective Norepinephrine Reuptake Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for Selective Norepinephrine Reuptake Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: World 15-Year Perspective for Selective Norepinephrine Reuptake Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 36: World Historic Review for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: World 15-Year Perspective for Other Drug Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Dyslexia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 38: USA Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: USA Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: USA 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 42: USA Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: USA 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: USA Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: USA 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
CANADA
TABLE 47: Canada Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: Canada 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: Canada 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 53: Canada Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: Canada 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
JAPAN
Dyslexia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 56: Japan Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: Japan 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: Japan 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 62: Japan Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: Japan 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
CHINA
Dyslexia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 65: China Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: China Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: China 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: China Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: China 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 71: China Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: China Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: China 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
EUROPE
Dyslexia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 74: Europe Recent Past, Current & Future Analysis for Dyslexia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Dyslexia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: Europe 15-Year Perspective for Dyslexia Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: Europe 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: Europe 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 83: Europe Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: Europe 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
FRANCE
Dyslexia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 86: France Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: France Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: France 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: France Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: France 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 92: France Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: France Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: France 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
GERMANY
Dyslexia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 95: Germany Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: Germany 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: Germany 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 101: Germany Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: Germany Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: Germany 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
ITALY
TABLE 104: Italy Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: Italy 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 109: Italy 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 110: Italy Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Italy Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 112: Italy 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
UNITED KINGDOM
Dyslexia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 113: UK Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: UK Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 115: UK 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: UK Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 118: UK 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 119: UK Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 120: UK Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 121: UK 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
SPAIN
TABLE 122: Spain Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: Spain Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 124: Spain 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 125: Spain Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 126: Spain Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 127: Spain 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 128: Spain Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: Spain Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 130: Spain 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
RUSSIA
TABLE 131: Russia Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 132: Russia Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 133: Russia 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 134: Russia Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: Russia Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 136: Russia 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 137: Russia Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 138: Russia Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 139: Russia 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Rest of Europe Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 142: Rest of Europe 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 144: Rest of Europe Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 145: Rest of Europe 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: Rest of Europe Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 148: Rest of Europe 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Dyslexia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Dyslexia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 150: Asia-Pacific Historic Review for Dyslexia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 151: Asia-Pacific 15-Year Perspective for Dyslexia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 153: Asia-Pacific Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 154: Asia-Pacific 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 156: Asia-Pacific Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 157: Asia-Pacific 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 159: Asia-Pacific Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 160: Asia-Pacific 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
AUSTRALIA
Dyslexia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 161: Australia Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 162: Australia Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 163: Australia 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 164: Australia Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 165: Australia Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 166: Australia 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 167: Australia Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 168: Australia Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 169: Australia 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
INDIA
Dyslexia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 170: India Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 171: India Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 172: India 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 173: India Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 174: India Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 175: India 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 176: India Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 177: India Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 178: India 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 179: South Korea Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 180: South Korea Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 181: South Korea 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 182: South Korea Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 183: South Korea Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 184: South Korea 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 185: South Korea Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 186: South Korea Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 187: South Korea 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 189: Rest of Asia-Pacific Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 192: Rest of Asia-Pacific Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 195: Rest of Asia-Pacific Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
LATIN AMERICA
Dyslexia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 197: Latin America Recent Past, Current & Future Analysis for Dyslexia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 198: Latin America Historic Review for Dyslexia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 199: Latin America 15-Year Perspective for Dyslexia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 200: Latin America Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 201: Latin America Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 202: Latin America 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 203: Latin America Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 204: Latin America Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 205: Latin America 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 206: Latin America Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 207: Latin America Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 208: Latin America 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 209: Argentina Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 210: Argentina Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 211: Argentina 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 212: Argentina Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 213: Argentina Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 214: Argentina 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 215: Argentina Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 216: Argentina Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 217: Argentina 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
BRAZIL
TABLE 218: Brazil Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 219: Brazil Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 220: Brazil 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 221: Brazil Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 222: Brazil Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 223: Brazil 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 224: Brazil Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 225: Brazil Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 226: Brazil 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
MEXICO
TABLE 227: Mexico Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 228: Mexico Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 229: Mexico 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 230: Mexico Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 231: Mexico Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 232: Mexico 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 233: Mexico Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 234: Mexico Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 235: Mexico 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 237: Rest of Latin America Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 238: Rest of Latin America 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 240: Rest of Latin America Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 241: Rest of Latin America 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 243: Rest of Latin America Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 244: Rest of Latin America 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
MIDDLE EAST
Dyslexia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 245: Middle East Recent Past, Current & Future Analysis for Dyslexia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 246: Middle East Historic Review for Dyslexia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 247: Middle East 15-Year Perspective for Dyslexia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 248: Middle East Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 249: Middle East Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 250: Middle East 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 251: Middle East Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 252: Middle East Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 253: Middle East 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 254: Middle East Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 255: Middle East Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 256: Middle East 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
IRAN
TABLE 257: Iran Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 258: Iran Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 259: Iran 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 260: Iran Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 261: Iran Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 262: Iran 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 263: Iran Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 264: Iran Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 265: Iran 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
ISRAEL
TABLE 266: Israel Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 267: Israel Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 268: Israel 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 269: Israel Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 270: Israel Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 271: Israel 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 272: Israel Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 273: Israel Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 274: Israel 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 276: Saudi Arabia Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 277: Saudi Arabia 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 279: Saudi Arabia Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 280: Saudi Arabia 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 282: Saudi Arabia Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 283: Saudi Arabia 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 284: UAE Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 285: UAE Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 286: UAE 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 287: UAE Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 288: UAE Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 289: UAE 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 290: UAE Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 291: UAE Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 292: UAE 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 294: Rest of Middle East Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 295: Rest of Middle East 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 297: Rest of Middle East Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 298: Rest of Middle East 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 300: Rest of Middle East Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 301: Rest of Middle East 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030
AFRICA
Dyslexia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 302: Africa Recent Past, Current & Future Analysis for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 303: Africa Historic Review for Dyslexia Treatment by Type - Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 304: Africa 15-Year Perspective for Dyslexia Treatment by Type - Percentage Breakdown of Value Sales for Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia and Other Types for the Years 2015, 2025 & 2030
TABLE 305: Africa Recent Past, Current & Future Analysis for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 306: Africa Historic Review for Dyslexia Treatment by Distribution Channel - Retail Pharmacies, Online Pharmacies and Hospital Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 307: Africa 15-Year Perspective for Dyslexia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Pharmacies and Hospital Pharmacies for the Years 2015, 2025 & 2030
TABLE 308: Africa Recent Past, Current & Future Analysis for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 309: Africa Historic Review for Dyslexia Treatment by Drug Class - Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 310: Africa 15-Year Perspective for Dyslexia Treatment by Drug Class - Percentage Breakdown of Value Sales for Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors and Other Drug Classes for the Years 2015, 2025 & 2030